Bio-Techne Corporation Bio-Techne Corporation

Bio-Techne Corporation

TECH

Kedudukan dalam Saham #1871
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Harga Saham
$72.55
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$11.38B
Perubahan (1 hari)
0.03%
Perubahan (1 tahun)
17.27%
Negara
US
Perdagangan Bio-Techne Corporation (TECH)

Kategori

Healthcare
Bilangan saham terbitan bagi Bio-Techne Corporation (TECH)
Bilangan saham terbitan setakat June 2026: 155.96M
Menurut laporan kewangan terkini dan harga saham Bio-Techne Corporation, bilangan saham terbitan semasa ialah 155.96M. Pada akhir June 2024, syarikat mempunyai 157.71M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Bio-Techne Corporation (TECH) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 155.96M -0.99%
2025 157.52M -0.12%
2024 157.71M 0.34%
2023 157.18M 0.19%
2022 156.88M 1.22%
2021 154.99M 1.43%
2020 152.80M 1.11%
2019 151.12M 0.81%
2018 149.90M 0.44%
2017 149.25M 0.32%
2016 148.78M 0.26%
2015 148.38M 0.56%
2014 147.56M 0.15%
2013 147.34M -0.28%
2012 147.76M -0.43%
2011 148.39M -0.42%
2010 149.02M -1.45%
2009 151.21M -3.42%
2008 156.56M -0.68%
2007 157.62M 0.91%
2006 156.20M -3.25%
2005 161.44M -1.67%
2004 164.18M -0.78%
2003 165.48M -0.33%
2002 166.03M 0.17%
2001 165.75M 2.00%
2000 162.50M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
253.90M 62.80%
US
396.00M 153.91%
US
478.91M 207.07%
AU
- -
CH
62.19M -60.13%
NL